You searched for:

905 results

Transition of COVID treatments to routine pathways

Classification: Official Publication reference: PR00337 27 March 2023 To: Integrated care board (ICB) chief medical officers (CMOs) ICB COVID therapeutics senior responsible officer (SROs) Regional chief pharmacists cc: Integrated care board: Directors of commissioning Chief operating officers Lead pharmacists Dear Colleagues, Transition of COVID treatments to routine pathways Thank you for the work you and […]

Commissioning Framework: COVID-19 therapeutics for non-hospitalised patients

The purpose of this commissioning framework is to support integrated care boards (ICBs) as commissioners of COVID-19 therapeutics for non-hospitalised patients who will benefit from them the most. This framework is intended to assist ICBs in establishing and maintaining timely access to COVID-19 therapeutics during the remainder of 2022/23 in preparation for routine provision from April 2023.